Business Standard

Wednesday, February 12, 2025 | 04:27 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Price cap on cancer drugs likely to dent profit margins of hospitals

Industry insiders pointed out that almost 70% of oncology drugs are sold through the hospital channel

Price cap on cancer drugs likely to dent profit margins of hospitals
Premium

Sohini DasAneesh Phadnis Mumbai
With India’s drug pricing authority capping the trade margins of 42 cancer drugs at 30 per cent, profit margins of hospitals which are already under stress are expected to come under pressure. 

Industry insiders pointed out that almost 70 per cent of oncology drugs are sold through the hospital channel. 

The government’s move, however, is unlikely to affect pharma companies. The new notified formula for fixing the maximum retail price (MRP) of 42 cancer drugs is based on the price at the first point of sale of the product or price to stockists. 

Trade margin is the difference between the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in